We are live on ! Find out more
FMI

Foundation Medicine, Inc.
FMI

Delisted

FMI was delisted on the 30th of July, 2018.

99 hedge funds and large institutions have $239M invested in Foundation Medicine, Inc. in 2015 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 13 (+2)

100% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 11

11% more funds holding

Funds holding: 8999 (+10)

7% more capital invested

Capital invested by funds: $224M → $239M (+$15.1M)

4% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 26

19% less call options, than puts

Call options by funds: $9.77M | Put options by funds: $12.1M

Holders
99
Holders Change
+10
Holders Change %
+11.24%
% of All Funds
2.6%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.08%
New
22
Increased
27
Reduced
26
Closed
11
Calls
$9.77M
Puts
$12.1M
Net Calls
-$2.34M
Net Calls Change
+$11.8M
Name Holding Trade Value Shares
Change
Change in
Stake
HP
26
Harbourvest Partners
Massachusetts
$1.19M
PIM
27
Platinum Investment Management
Australia
$1.16M +$1.06M +55,000 New
T. Rowe Price Associates
28
T. Rowe Price Associates
Maryland
$1.16M
Susquehanna International Group
29
Susquehanna International Group
Pennsylvania
$1.05M -$1.67M -86,414 -63%
Charles Schwab
30
Charles Schwab
California
$968K -$116K -6,027 -12%
BIM
31
BlackRock Investment Management
Delaware
$839K +$4.11K +213 +0.5%
Zurich Cantonal Bank
32
Zurich Cantonal Bank
Switzerland
$834K +$27.5K +1,429 +4%
WT
33
Whittier Trust
California
$828K +$758K +39,352 New
ST
34
Spot Trading
Illinois
$809K -$5.13M -266,120 -87%
Morgan Stanley
35
Morgan Stanley
New York
$800K +$486K +25,206 +198%
TCIM
36
TIAA CREF Investment Management
New York
$781K -$197K -10,228 -22%
ProShare Advisors
37
ProShare Advisors
Maryland
$620K +$40K +2,075 +8%
Royal Bank of Canada
38
Royal Bank of Canada
Ontario, Canada
$549K -$17K -883 -3%
AIG
39
American International Group
New York
$537K +$357K +18,546 +265%
BAMCO Inc
40
BAMCO Inc
New York
$478K -$1.06M -54,800 -71%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$464K +$7.3K +379 +2%
BBA
42
Baker Bros. Advisors
New York
$440K
LCM
43
Landscape Capital Management
New Jersey
$436K +$399K +20,726 New
AllianceBernstein
44
AllianceBernstein
Tennessee
$413K -$42.4K -2,200 -10%
PG
45
PEAK6 Group
Illinois
$407K +$6.88K +357 +2%
LPL Financial
46
LPL Financial
California
$389K +$379K +19,660 New
DADC
47
D.A. Davidson & Co
Montana
$383K +$351K +18,216 New
TA
48
Teachers Advisors
New York
$381K
DekaBank Deutsche Girozentrale
49
DekaBank Deutsche Girozentrale
Germany
$379K +$5.78K +300 +2%
Swiss National Bank
50
Swiss National Bank
Switzerland
$346K

FMI Hedge Fund Activity: Q4 2015 in Review

99 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q4 2015, worth a combined $239M — up 6.7% from $224M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FMI positions and 11 closed out — a net gain of 11 holders — while 27 added to existing stakes and 26 trimmed.

The largest buyer was Michael R. Murphy, adding an estimated $6.59M. The largest seller was Bain Capital Public Equity Management, exiting entirely with an estimated $18.1M sold.

  • 99 institutional investors held Foundation Medicine, Inc. (FMI) as of Q4 2015, up from 89 in Q3 2015.
  • Funds reported $239M of Foundation Medicine, Inc. stock for Q4 2015, up 6.7% quarter-over-quarter.
  • 22 funds opened new Foundation Medicine, Inc. positions in Q4 2015 and 11 closed out, a net change of +11 holders.
  • The largest Foundation Medicine, Inc. buyer in Q4 2015 was Michael R. Murphy, an estimated $6.59M added.
  • The largest Foundation Medicine, Inc. seller in Q4 2015 was Bain Capital Public Equity Management, an estimated $18.1M sold.

Based on aggregated 13F filings for Q4 2015.